Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 7Neoplasms 2Margins of Excision 1Esophageal Diseases 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Anastomotic Leak 1

Interventions

pembrolizumab 90Blood Specimen Collection 41Cyclophosphamide 37Bevacizumab 36Nivolumab 35Standard of Care 32Carboplatin 31Surveys and Questionnaires 29Paclitaxel 27atezolizumab 25Exercise 25Pemetrexed 24Gemcitabine 23Cisplatin 23Fluorouracil 22Radiotherapy 20Leucovorin 20Dexamethasone 20Docetaxel 19Oxaliplatin 18Rituximab 16Irinotecan 16Cetuximab 16dostarlimab 15Drug Therapy 15Doxorubicin 15Ipilimumab 14Biopsy 14130-nm albumin-bound paclitaxel 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Esophagectomy × 1 year × Clear all
NCT07567716 2026-05-05

Infiltration Pattern of Locally Advanced ESCC

Shanghai Chest Hospital

Enrolling by invitation
30 enrolled
Gastrointestinal

Margins of Excision, Esophageal Squamous Cell Carcinoma, Neoplasms

NCT00937456 2026-04-22

Open Versus Laparoscopically-assisted Esophagectomy for Cancer

University Hospital, Lille

Phase NA Completed
207 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡